Literature DB >> 7789960

Highly polymorphic dinucleotide repeat at the NF2 gene.

D Bourn1, T Strachan.   

Abstract

A highly polymorphic CA repeat was identified in a cosmid containing the 5' end of the NF2 tumour suppressor gene. This marker has proved useful in presymptomatic diagnosis in affected families.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7789960     DOI： 10.1007/bf00209494

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  1 in total

1.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582
  1 in total
  8 in total

1.  Hereditary spinal neurofibromatosis: a rare form of NF1?

Authors:  M Poyhonen; E L Leisti; S Kytölä; J Leisti
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.

Authors:  C L Wu; N Thakker; W Neary; G Black; R Lye; R T Ramsden; A P Read; D G Evans
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

3.  Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.

Authors:  A Mohyuddin; W J Neary; A Wallace; C L Wu; S Purcell; H Reid; R T Ramsden; A Read; G Black; D G R Evans
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

4.  Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

Authors:  L B Jacoby; D Jones; K Davis; D Kronn; M P Short; J Gusella; M MacCollin
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

5.  Misleading linkage results in an NF2 presymptomatic test owing to mosaicism.

Authors:  E K Bijlsma; A J Wallace; D G Evans
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

6.  A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.

Authors:  E Ars; H Kruyer; A Gaona; P Casquero; J Rosell; V Volpini; E Serra; C Lázaro; X Estivill
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.

Authors:  D G Evans; L Trueman; A Wallace; S Collins; T Strachan
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

8.  Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.

Authors:  Nives Pećina-Slaus; Martina Zeljko; Hrvoje Ivan Pećina; Tamara Nikuseva Martić; Niko Bacić; Davor Tomas; Reno Hrasćan
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.